PPA
ASTH icon

Pilgrim Partners Asia’s Astrana Health ASTH Stock Holding History

Pilgrim Partners Asia’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$73.2K Buy
2,360
+1,100
+87% +$36.6K 0.07% 46
2024
Q4 		$39.7K Buy
+1,260
New +$59.8K 0.03% 104

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pilgrim Partners Asia's ASTH Position: Q1 2025 in Review

Pilgrim Partners Asia increased its Astrana Health (ASTH) stake by 87% in Q1 2025, buying an estimated $36.6K and bringing the position to 2,360 shares worth $73.2K. The position accounts for 0.07% of the portfolio, ranked #46.

Pilgrim Partners Asia first reported a position in ASTH in Q4 2024 and has held it in 2 quarters since. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • Pilgrim Partners Asia held 2,360 shares of Astrana Health worth $73.2K as of Q1 2025.
  • Pilgrim Partners Asia bought 1,100 Astrana Health shares in Q1 2025, an estimated $36.6K.
  • Astrana Health made up 0.07% of Pilgrim Partners Asia's portfolio in Q1 2025, its #46 holding.
  • Pilgrim Partners Asia first reported a position in Astrana Health in Q4 2024 and has held it in 2 quarters since.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on Pilgrim Partners Asia's 13F filing for Q1 2025, filed 14 May 2025.